Antibiotics (HS 2941); Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) (HS 3003); Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006) (HS 3004); Wadding, gauze, bandages and the like, e.g. dressings, adhesive plasters, poultices, impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposes (HS 3005); Pharmaceutical preparations and products of subheadings 3006.10.10 to 3006.60.90 (HS 3006)

Extension of comment period for the Draft Resolution number 989.

The final date for comments of the Draft Resolution number 989, 15 December 2020 – previously notified through G/TBT/N/BRA/1118 – which changes the Resolution – RDC number 47, 8 September 2009, which establishes technical requirements for the development, harmonization, updating, publication, and provision of medicine leaflets to patients and healthcare professionals, was extended for 15 days.